Literature DB >> 19367297

A case study of the New York City trans-fat story for international application.

Andy S L Tan1.   

Abstract

Heart disease is the leading cause of death in New York City and contributes to significant burden of disease in the United States and internationally. Excessive intake of artificial trans-fatty acids has been causally associated with increased risk of heart disease. This article describes New York City's 2007 trans-fatty acids regulation, which was aimed at lowering the prevalence of heart disease among the city's residents by prohibiting the use of trans-fatty acids in the preparation of food in the city's food outlets. The author describes sequentially: (1) formulation, (2) public consultation, (3) implementation and (4) evaluation of the policy. He proposes a strategic framework for food policy development for international policymakers who are considering similar regulations. The framework includes four domains: (1) background research, (2) stakeholder support, (3) effective policy implementation and (4) evaluation and dissemination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367297     DOI: 10.1057/jphp.2008.42

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  3 in total

1.  The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists.

Authors:  Ryan T Hurt; Christopher Kulisek; Laura A Buchanan; Stephen A McClave
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-12

2.  Understanding the Complexities of Eliminating Trans Fatty Acids: The Case of the Trans Fatty Acid Ban in Thailand.

Authors:  Weerapak Samsiripong; Sirinya Phulkerd; Umaporn Pattaravanich; Manasigan Kanchanachitra
Journal:  Nutrients       Date:  2022-07-01       Impact factor: 6.706

3.  A Delphi study for exploring nutritional policy priorities to reduce prevalence of non-communicable diseases in Islamic Republic of Iran.

Authors:  Hassan Eini Zinab; Naser Kalantari; Alireza Ostadrahimi; Jafar Sadegh Tabrizi; Samira Pourmoradian
Journal:  Health Promot Perspect       Date:  2019-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.